Reconsidering functional outcomes in watch-and-wait rectal cancer after total neoadjuvant treatment重新评估总新辅助治疗后观察等待策略下直肠癌的功能结局Radiotherapy and OncologyIF5.32026-05-010PRE
Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US局部晚期直肠癌经完全新辅助治疗后生活质量与晚期毒性的评估 – LARCT-USRadiotherapy and OncologyIF5.32025-11-280OAAI
Locoregional control following TNT using short-course radiotherapy in rectal cancer: long-term results from the Swedish LARCT-US studyBJS-BRITISH JOURNAL OF SURGERYIF02025-08-010OA
Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)ECLINICALMEDICINEIF102024-09-010OAAI
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancerINTERNATIONAL JOURNAL OF CANCERIF4.72024-02-202OA
Mucinous rectal cancers: clinical features and prognosis in a population-based cohortBJS OPENIF4.52022-04-268OAAI
Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?RADIOTHERAPY AND ONCOLOGYIF5.32021-04-0118OAAI
Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelinesRADIOTHERAPY AND ONCOLOGYIF5.32019-07-0110PREAI